.jpg)
.png)
Fall 2022
Nonalcoholic fatty liver disease (NAFLD) contributes to cardiovascular disease risk through dyslipidemia, insulin resistance, altered coagulation states, and increased inflammation. NAFLD occurs in greater than 25% of individuals worldwide. Its prevalence is highest in the U.S. Hispanic population... more
Background Incretins are hormones secreted by intestinal cells in response to the ingestion of glucose and other nutrients. These hormones stimulate pancreatic β cells to secrete insulin and are essential to maintaining normal glucose homeostasis. The insulinotropic effect of incretins is... more
With recent guideline changes, it is common for clinicians to field questions regarding aspirin therapy. This article is intended to help clinicians apply an individualized and evidence-based approach to the appropriate use of aspirin in specific at-risk patient populations. Aspirin’s Role in... more
Introduction ‘Adulting’ refers to the practice of behaving in a manner or characteristic of a responsible adult in order to successfully complete necessary, although at times mundane tasks.1 Mastering seven basic skill sets are considered necessary to successfully become an adult, referred to as... more
Atherosclerosis is a progressive disease that affects us throughout our lifetime. Although we know a lot about its process, much more needs to be elucidated. One of my professors said, “the best statin in the world will only reduce cardiovascular events by 50%; our challenge is what causes... more
Q: Why do you support DE&I for NLA? A: I believe that people from all walks of life, regardless of their color, sex, socioeconomic status, and religion should be equally respected. We should see them as who they are rather than what they appear as externally. I feel that the concept of DE... more
Introduction Obesity is a chronic, relapsing, heterogenous disease characterized by impaired energy regulation and inflammation... more
Introduction Cardiometabolic syndrome, also known as “metabolic syndrome,” refers to a constellation of metabolic abnormalities and cardiovascular risk factors clustered in a given patient. The definitions have varied over time, but all retain key features (Table). There has been debate as to... more
This issue is sponsored by the Northeast and Southeast Lipid Associations
Cardiometabolic Disease and Polyphenols Cardiometabolic disease is the concurrence of several disease states, including impaired glucose tolerance, hypertension, dyslipidemia, and visceral adiposity. These risk factors predispose patients to chronic diseases such as type 2 diabetes mellitus,... more